Shake-up at Valeant signals stunning fall from grace for J Michael Pearson
Pharmaceutical giant faces a growing list of questions from investors and regulators
Drugmaker Valeant pulls forecasts as Pearson returns
Chief executive back at the helm after two-month absence through illness but Robert Ingram retains chairman’s post
Massive increases in medicine prices leave nasty taste
Pharma companies’ method of buying drug makers and racking up costs is a threat to R&D
Company making ‘female Viagra’ sold to Valeant for $1bn
Deal comes days after final US approval for controversial drug
Valeant raises forecasts after topping expectations in first quarter
Fast-growing company loses CFO Howard Schiller as it looks to address issues with $11bn Salix Pharma acquisition
Europe rallies but Iseq finishes down
European stock markets continue to enjoy lift from ECB’s quantitative easing
Salix accepts takeover offer from Valeant
Pharma group accepts higher bid as Dublin based bidder Endo withdraws
AbbVie boosts cancer drug pipeline with Pharmacyclics deal
Company to pay $261.25 per share in cash and stock
Salix calls off Irish-based ‘inversion’ merger
US pharma company scraps deal with Italian firm Cosmo Pharmaceuticals
Salix blames new US rules for abandoning Irish merger
US pharmaceutical company had hoped to gain Irish tax base
Shareholder advisory firm calls for vote on aquisitions at Allergan
Botox maker’s board faces credibility problem, says ISS
Salix to gain Irish HQ through merger
US pharmaceuticals group will merge with Dublin-based Cosmo Technologies to reduce its tax bill
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices